IRIDEX receives Nasdaq minimum bid price deficiency notice; 180-day cure period

IRIDEX CORP

Nasdaq notified IRIDEX on Aug 27, 2026 that bid price below $1.00 for 30 consecutive business days.
Company has 180 days, until Feb 23, 2027, to regain compliance by closing at ≥$1.00 for 10 consecutive days.
Failure may allow second 180-day period if IRIDEX meets other listing standards and intends to cure via reverse split.
If not cured, Nasdaq may delist; company may appeal. No immediate impact on listing or operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.